From lab to certified product
OxVent-P has proven technical feasibility at TRL 4. With ~£60k investment we reach TRL 6 — with a market led product design by end of 2027.
TRL Progress
AchievedCurrent — TRL 4Target with investment — TRL 6Future
With ~£60,000 we can deliver an innovative product in 15 months
Every pound goes directly toward getting OxVent-P to the clinicians who need it.
Fractional Resources
Experienced MedTech professionals on a part-time fractional basis.
Product Design
Refine OxVent-P industrial design, form factor and user interface.
ISO Certifications
Test and certify hardware and software to ISO 13485 and IEC standards.
Real User Testing
LMIC partner teardowns, demonstrations and clinician feedback.
Early Adopters
Identify and onboard initial clinical deployment partners.
FDA Readiness
Begin preparation for US FDA regulatory submission pathway.
OUR PRODUCT VISION: THEN · NOW · NEXT · WOW
From the original COVID-19 ventilator to an off-grid solar ventilator — OxVent’s product vision is ambitious and purposeful.
THEN
OxVent
Original COVID-19 ventilator. ISO 13485 accredited manufacturing (Dec 2021). Built from standardised parts for mass production.
Status: Complete
NOW
OxVent-P
Venturi-driven. Neonatal to adult. Low-resource settings. Simple UX, designed for local manufacture and servicing.
Status: Active ← We are here
NEXT
OxVent-P+
Augmented with oxygen concentrators, CO2 scrubbers, and IoT notifications for small clinical teams.
Status: Future
WOW
OxVent-PX
Solar compressed-air ventilation for hard-to-reach locations with little or no infrastructure.
Status: Vision